There are three major isoforms of BAG-1 in mammalian cells, termed BAG-1L (p50), BAG-1M (p46) and BAG-1S (p36) that function as pro-survival proteins and are associated with tumorigenesis and chemoresistance. Initiation of BAG-1 protein synthesis can occur by both capdependent and cap-independent mechanisms and it has been shown that synthesis of BAG-1S is dependent upon the presence of an internal ribosome entry segment (IRES) in the 5 0 -UTR of BAG-1 mRNA. We have shown previously that BAG-1 IRES-meditated initiation of translation requires two trans-acting factors poly (rC) binding protein 1 (PCBP1) and polypyrimidine tract binding protein (PTB) for function. The former protein allows BAG-1 IRES RNA to attain a structure that permits binding of the ribosome, while the latter protein appears to be involved in ribosome recruitment. Here, we show that the BAG-1 IRES maintains synthesis of BAG-1 protein following exposure of cells to the chemotoxic drug vincristine but not to cisplatin and that this is brought about, in part, by the relocalization of PTB and PCBP1 from the nucleus to the cytoplasm.
Introduction
BAG-1 is a multifunctional protein that has a role in a range of cellular processes including apoptosis, cell survival, transcription, cell motility and proliferation (Townsend et al., 2003b) . The involvement of BAG-1 in these different cellular pathways can be, in part, explained by the subcellular compartmentalization of the three major BAG-1 isoforms (p50, p46 and p36), which have distinct N-termini (Cato and Mink, 2001) . Thus the largest isoform p50 (BAG-1L) contains a nuclear localization sequence in the N-terminal extension (Cato and Mink, 2001 ) and resides in the nucleus, while the most abundant form of the protein p36 (BAG-1S) is found predominately in the cytoplasm. BAG-1 interacts via its C-terminus (the BAG domain), with a large number of disparate proteins including BCL2, RAF-1, nuclear hormone receptors, subunits of the ubiquitinylation proteasome complex and Hsc70 and Hsp70 Zeiner et al., 1997; Bimston et al., 1998; Gebauer et al., 1998) . BAG-1 expression is known to protect cells from a wide range of apoptotic stimuli (Bardelli et al., 1996; Clevenger et al., 1997; Takayama et al., 1997) and it has been proposed that the pro-survival effects of BAG-1 are due to its interaction with Hsc70 and Hsp70 (Jolly and Morimoto, 2000) .
BAG-1 expression is highly regulated and since the three major isoforms are generated from a single mRNA transcript (Yang et al., 1998) , translational regulation is thought to play a major role in the control of their expression (Yang et al., 1998; Coldwell et al., 2001) . The p50 and p46 isoforms are translated by cap-dependent mechanisms whereby a complex of proteins (eukaryotic initiation factor 4F; eIF4F) binds to the 7-methylguanosine cap structure at the 5 0 end of the message and the 40S ribosomal subunit interacts with this complex (Pain, 1996) . In contrast, it has been shown that initiation of synthesis of the p36 isoform of BAG-1 occurs by the alternative mechanism of internal ribosome entry (Coldwell et al., 2001) . In this method of translation initiation, the ribosome is recruited to a highly structured RNA element termed an internal ribosome entry site/segment (IRES). The BAG-1 IRES adopts a very complex structure containing four stem loops and a RNA pseudoknot (Pickering et al., 2004) . Cellular IRESs are generally required to maintain translation of specific proteins under circumstances where cap-dependent translation is compromised, including during apoptosis (Holcik et al., 2000; Stoneley et al., 2000; Bushell et al., 2006) , hypoxia (Akiri et al., 1998; Stein et al., 1998) and mitosis (Qin and Sarnow, 2004) ; the BAG-1-1 IRES has been shown to be required during heat shock (Coldwell et al., 2001) . Most cellular IRESs require trans-acting factors that are thought to allow the RNA to adopt the correct conformation and to assist binding of the 40S ribosomal subunit. It has been shown that the BAG-1 IRES requires polypyrimidine tract binding protein (PTB) and poly (rC) binding protein 1 (PCBP1) for activity and the data suggest that PCBP1 is required to remodel the BAG-1 IRES RNA, while PTB is needed for ribosome recruitment (Pickering et al., 2003 (Pickering et al., , 2004 .
Given the role of BAG-1 in a number of different biological pathways it is not surprising that deregulated BAG-1 expression is associated with tumorigenesis (Tang et al., 1999; Hague et al., 2002; Townsend et al., 2002) ; moreover, cells overexpressing BAG-1S are protected from apoptosis and are resistant to the effects of chemotoxic drugs (Townsend et al., 2003a) . Cellular stress brought about by exposure of cells to a range of external stimuli including chemotoxic drugs generally results in a decrease in cap-dependent translation. Therefore, we have investigated whether synthesis of BAG-1S is maintained under these conditions and the involvement of PCBP1 and PTB in this process.
Protein synthesis is inhibited following exposure of cells to vincristine and cis-platinum(II)diamine dichloride HeLa cells were treated with a range of doses of vincristine and cis-platinum(II)diamine dichloride (cisplatin) for either 12 or 24 h to determine the degree of inhibition of protein synthesis following exposure. After 24 h there was a large decrease in the level of protein synthesis with both drugs and exposure of cells to 6 nM vincristine ( Figure 1ai ) and 10 mM cisplatin (Figure 1aii ) decreased synthesis rates to 30-40% (Figures 1ai and ii ; smaller effects were observed after 12 h; data not shown). Western analysis was performed to determine the effects of 24 h exposure on the translation apparatus. Thus cells were treated with the chemotoxic agents at the concentrations shown then lysed, proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred to nitrocellulose and probed using antibodies directed against eIF4G, eIF4E, eIF4EP, eIF2a, eIF2aP and 4EBP1. The reduction in translation in cells treated with cisplatin is caused by a decrease in the phosphorylation of 4EBP1; this would result in the sequestration of eIF4E by 4EBP1, prevent eIF4F complex formation and inhibit cap-dependent translation and a decrease in the phosphorylation of eIF4E, which would reduce the affinity of this protein for the 7-methyl-guanosine cap (Figure 1b) . In contrast in cells treated with vincristine, there is a phosphorylation of eIF2 at the alpha subunit that would reduce the levels of ternary complex and inhibit translation (Figure 1b) . Rather surprisingly in these cells an increase in the phosphorylated form of 4EBP1 was observed. While the significance of this is not clear, increased 4F complex formation during cellular stress has been shown to occur under other conditions where translation is inhibited (Fraser et al., 1999) .
The BAG-1 IRES allows continued synthesis of BAG-1 in vincristine-treated cells To determine whether BAG-1 protein was still synthesized during these conditions, cells were treated with either cisplatin or vincristine at the doses shown and after 24 h incubated with 35 S-methionine for 30 min before harvesting. The BAG-1 proteins were immunoprecipitated using an antibody that recognizes all three isoforms (Coldwell et al., 2001) . Only the p50 and p36 isoforms were immunoprecipitated in agreement with the previous data (Coldwell et al., 2001; Figure 2a) . Following exposure of cells to increasing amounts of vincristine there was a decrease in the expression of the p50 isoform but importantly continued synthesis of the p36 isoform whose translation we have shown previously is initiated by the alternative mechanism of internal ribosome entry (Figure 2ai ). In contrast, there was no new synthesis of BAG-1 isoforms following exposure of cells to 4 mM cisplatin (Figure 2aii ). Interestingly, it has been shown previously that overexpression of p36 did not affect growth inhibition induced by cisplatin (Townsend et al., 2003a) and it is likely that different pathways are used to maintain BAG-1 expression following exposure of cells to this agent.
We have generated previously a series of monocistronic plasmid constructs to test IRES function (Coldwell et al., 2001) . Thus, the plasmid phpL contains a stable hairpin upstream of firefly luciferase, which is sufficient to strongly inhibit the majority of cap-dependent scanning (to 5-10% of the level produced from pGL3), while the presence of the BAG-1 5 0 -UTR in the construct phpBL allows BAG-IRES-mediated translation ( Figure 2b ; (Coldwell et al., 2001) ). To determine whether the BAG-1 IRES was used to maintain BAG-1 synthesis following the treatment of cells with chemotoxic drugs, HeLa cells were transfected with the constructs phpL, phpBL and pGL3, exposed to the concentrations of drugs shown and harvested and luciferase activity was determined ( Figure 2c ). Luciferase activity derived from phpL or pGL3 decreased to around 20-30% of the level of luciferase observed in untreated cells at all concentrations of vincristine applied. However, only a slight decrease in luciferase activity was observed in cells that harboured the constructs that contained the BAG-1 IRES (Figure 2ci ). This decrease is likely to be due to the inhibition of the small amount of cap-dependent initiation that still occurs in these constructs, but these data strongly suggest that the BAG-1 IRES is still functional in vincristine-treated cells. In contrast, in cisplatin-treated HeLa cells a decrease in firefly luciferase activity was observed from all constructs and the plasmid containing the BAG-1 IRES was not translated anymore efficiently than the control vector ( Figure 2cii ). These data correlate with the levels of synthesis of BAG-1 (Figure 2a ) and taken together strongly suggest that the BAG-1 IRES allows continued synthesis of BAG-1 proteins in cells treated with vincristine but not cisplatin. The degree of translational inhibition induced with these compounds was similar ( Figure 1a ) so it is likely that the very different responses of the BAG-1 IRES under these conditions reflect the distinct signalling pathways induced by these compounds.
The BAG-1 IRES functions following vincristine exposure HC Dobbyn et al
The BAG-1 IRES does not function during mitosis or apoptosis Vincristine acts by binding to the microtubular proteins of the mitotic spindle, leading to crystallization of the microtubule and mitotic arrest and as several cellular IRESs have been shown to function during mitosis (Cornelis et al., 2000; Pyronnet et al., 2001; Qin and Sarnow, 2004) , experiments were performed to determine whether mitotic arrest alone was sufficient for BAG-1 IRES function. HeLa cells were transfected with phpL, pGL3, phpBL and the transfected cells were treated with nocodazole or aphidicoline and harvested either immediately following exposure to these drugs or 2 h after the removal of the drugs (as detailed in the figure legend) to obtain populations of cells in mitosis, G 1 , S and G 2 and luciferase activity was determined ( Figure 3ai ). However, there was no difference between the levels of luciferase produced from phpBL compared to the control constructs at any stage of the cell cycle showing that activation of the BAG-1 IRES following treatment of cells with vincristine is not likely to be due to a mitotic block (Figure 3ai ). We have shown previously that cellular IRESs that control the synthesis of proteins that have a role in S methionine. At the end of the labelling period (20 min), cells were washed twice in PBS and then resuspended in a final volume of 1 ml PBS. Cell suspensions were then spotted in triplicates of 20 ml on to a piece of Whatman 3MM filter paper divided into squares, and the filter paper was dried. Filters were washed for 3 Â 15 min in 5% TCA and then 1 Â 15 min in methanol before drying and cutting into squares. Radioactivity was measured by scintillation counting. There was an inhibition of protein synthesis to 70% of the control level in cisplatin-treated cells and to 65% in vincristine-treated cells at the highest doses used. (b) HeLa cells were treated with the doses of vincristine or cisplatin shown (for 24 h), and immunoblotting was performed to determine the levels and phosphorylation states of eukaryotic initiation factors as described previously (West et al., 1998) . Rabbit polyclonal antibodies were used to detect phosphorylated eIF4E, eIF4E phosphorylated eIF2a, eIF2a, 4EBP1 and eIF4G and were the kind gifts from Dr S Morley (PeIF4E, eIF4E and eIF4G), Prof R Denton (4E-BP1) and Prof C Proud (eIF2a) respectively, and were used at the dilutions of 1:7000, 1: 2000, 1:1000, and 1:2000 and 1:2000 respectively. Blots were then stripped and reprobed with actin to ensure equal loading. Blots were then incubated with peroxidase-conjugated secondary antibodies raised against rabbit immunoglobulins and developed using the chemiluminescence reagent ECL (GE Healthcare, Amersham, UK) and the resulting X-ray film was then scanned.
The BAG-1 IRES functions following vincristine exposure HC Dobbyn et al apoptosis function efficiently following exposure of cells to TNF-related apoptosis inducing ligand (TRAIL; Stoneley et al. 2000; Bushell et al. 2006) . Therefore, to investigate whether the BAG-1 IRES was also functional during apoptosis, cells were transfected with phpBL, phpL and pGL3, exposed to TRAIL and luciferase activity was determined. However, the BAG-1 IRES did not maintain expression of firefly luciferase during TRAIL-induced apoptosis (Figure 3aiii) .
We have shown previously that PTB and PCBP1 are required for BAG-1 IRES function in vitro and in vivo, although it is likely that additional proteins are required Figure 2 The BAG-1 internal ribosome entry segment (IRES) is functional in vincristine-treated cells. (a) Immunoprecipitation of BAG-1 isoforms during chemotoxic stress was performed as described previously (Stoneley et al., 2000) . Cells were labelled with 35 Smethionine for 30 min before harvesting and the BAG-1 isoforms were immunoprecipitated overnight at 41C using a BAG-1 monoclonal antibody mix (3.9F1E1173.10G3E2, Lab Vision Products, Runcorn, UK). The data suggest that 24 h following treatment of cells with vincristine (i) but not cisplatin (ii) there is continued synthesis of the p36 isoform of BAG-1 when compared to the p50 isoform. (b) Schematic representation of the constructs used to measure IRES activity of BAG-1. The generation of these plasmids is described in detail by Coldwell et al. (2001) . (c) HeLa cells were transfected with the monocistronic hairpin vector phpBL (closed squares) or control vectors phpL (closed circles) or pGL3 (closed triangles) and 24 h post-transfection, vincristine (i) or cisplatin (ii) was applied to cells at the doses shown and 24 h later, cells were lysed and assayed for enzyme activity. Luciferase expression was assayed using the luciferase assay system (Promega) and normalized to the transfection control of b-galactosidase (cells were transfected with pcDNA3.1/HisB/lacZ from Invitrogen, Paisley, UK), which was assayed using the Galactolight plus assay system (Tropix). All light emissions were measured over 10 s using an Optocomp1 Luminometer (MGM instruments). Relative luciferase activity was calculated as the average of a proportion of the activity in untreated cells (firefly luciferase expression/b-Gal expression), and the efficiency was expressed as (luciferase activity in treated cells)/(luciferase activity in untreated control cells). Errors were calculated as the s.d. of the three calculated IRES activities, and expressed as a percentage of the average activity. All experiments were performed in triplicate on at least three independent occasions. There is continuation of luciferase production mediated by translation initiation through the BAG-1 IRES in vincristine but not cisplatin-treated cells. Closed squares, phpBL; closed circles, pGL3; closed triangles, phpL. The mitotic cells (found in suspension) were harvested and half of these cells were lysed and luciferase activity was determined (M), while the remaining cells were replated in fresh media and grown for a further 2 h (G 1 ). Transfected cells were also treated with aphidicoline (5 mg/ml), which prevents exit from S phase by inhibiting DNA synthesis. Again a proportion of these cells were harvested and assayed immediately following treatment (S), while the remainder were regrown in fresh media for a further 8 h to allow progression into G 2 when they were harvested. Cell samples were sorted by FACS to show arrest in the specific stages of the cell cycle (aii). Luciferase activity was measured for each population of cells, normalized to the transfection control (as described in the legend to Figure 2 ) and expressed relative to cells maintained in an asynchronous state. The data shows that there is no significant increase in BAG-1 IRES-mediated translation during the cell cycle. (aiii) HeLa cells were transfected with the monocistronic hairpin vector phpBL (closed squares) or control vectors phpL (closed circle) or pGL3 (closed triangle). At 40 h post-transfection, the medium was supplemented with His-tagged TRAIL to a final concentration of 0.25 mg/ml. Cells were harvested at 0, 2, 4, 6, 8 and 10 h after the addition of TRAIL and luciferase activity was determined. The BAG-1 IRES does not function in TRAIL-mediated apoptosis. Closed squares, phpBL; closed circles, pGL3; closed triangles phpL. (bi and ii) HeLa cells were treated with the doses of vincristine or cisplatin shown and after 24 h immunoblotting was performed to determine the levels of polypyrimidine tract binding protein 1 (PTB-1) and poly (rC) binding protein 1 (PCBP1). The PTB polyclonal rabbit antibodies were used at a concentration of 1:2000 and were a gift from Chris Smith. The data show that there was no change in the levels of these proteins.
for full activity of this IRES since the BAG-1 IRES is still less active in vitro in the presence of these proteins than in vivo (Pickering et al., 2003) . To address the role of PTB and PCBP1 in the maintenance of IRESmediated BAG-1 synthesis following exposure of cells to vincristine, cells were incubated with vincristine or cisplatin at the doses shown, lysed, proteins separated by SDS-PAGE and immunoblotted (Figures 3bi and ii) . It can be seen that there was no change in the levels of these proteins following exposure of the cells to either drug (Figures 3bi and ii) . Thus this would not account for function of the BAG-1 IRES following treatment of cells with vincristine.
PCBP1 and PTB relocalize following treatment of cells with vincristine
It is known that many of the proteins that are involved in IRES-mediated translation are able to shuttle between the nucleus and the cytoplasm (Michael et al., 1997; Kamath et al., 2001) thus it is possible that a relocation of PTB and PCBP1 from the nucleus to the cytoplasm could be required to activate the BAG-1 IRES. Indirect immunofluorescence was performed on control cells and cells that had been treated with vincristine and cisplatin to assess the localization of the BAG-1 IRES trans-acting factors during chemotoxic stress. PTB is a nuclear protein that has a role in splicing and as such is almost exclusively localized to the nucleus during normal cellular circumstances (Kamath et al., 2001; Wang et al., 2003) (Figure 4a) ; however, a very significant redistribution was observed on treatment of the cells with vincristine to the perinuclear ring ( Figure 4b ). In contrast to PTB, PCBP1 has a more even distribution between the cytoplasm and nucleus in control cells, in agreement with previous data that have shown that PCBP1 shuttles between the cytoplasm and the nucleus (Leffers et al., 1995) . Again, on application of a 24-h vincristine treatment, PCBP1 shows redistribution to the perinuclear ring (Figure 4b ). Merging the images of PTB and PCBP1 after vincristine treatment shows co-localization of the two proteins ( Figure 4b ) where they may enhance BAG-1 IRESdriven translation under vincristine-induced cell stress. To test whether PTB and PCBP1 also relocalize as a result of cisplatin treatment, indirect immunofluorescence HeLa cells were plated into chamber slides and treated with 4 nM vincristine, 4 mM of cisplatin or maintained under control conditions for 24 h. Cells were fixed using 1:1 acetone:methanol and proteins were bound by the addition of primary antibody. The localization of the proteins was determined using fluorescently labelled secondary antibodies and fluorescence microscopy.
The BAG-1 IRES functions following vincristine exposure HC Dobbyn et al was again performed. In this case there is not a significant relocalization of PTB after cisplatin treatment and the majority of PTB remains in the nucleus. In addition, there was no significant relocalization of PCBP1 after cisplatin treatment (Figure 4c ). In summary, our data show that in response of cells to vincristine, there is IRES-mediated synthesis of BAG-1 protein that is, in part, mediated by relocalization to the perinuclear ring of the IRES trans-acting factors PTB and PCBP1 and we have shown previously that PTB and PCBP1 act in concert to stimulate the BAG-1 IRES in vitro (Pickering et al., 2003 (Pickering et al., , 2004 ; Supplementary data 1). Elucidation of the mechanisms that lead to redistribution of PTB and PCBP1 would give valuable insights into the pathways that lead to regulation of BAG-1 IRES activity. PTB has been studied in this regard and changes in subcellular localization can be mediated by cleavage and loss of the nuclear localization sequence (NLS) or phosphorylation at a site adjacent to the NLS (Back et al., 2002; Xie et al., 2003) ; however, no change in the size of PTB-1 was observed following vincristine treatment (Figure 3b ) and no increase in phosphorylation of PTB was detected (using a phosphor-specific antibody; data not shown). Further studies are in progress to investigate the signalling pathways involved in the relocation of these proteins. Interestingly, we have also found that PTB-1 and PCBP1 relocalize in the cytoplasm following heat shock (data not shown) suggesting that similar signalling pathways may also be used for this response.
